Phylomics produces an innovative blood test used by doctors to detect multiple types of cancers in asymptomatic patients. By producing a cancer screening used as part of an annual physical, Phylomics detects cancer early—when treatment is most effective. Phylomics’ analysis is highly predictive and can detect a growing number of cancers including breast, prostate, pancreatic, lung, ovarian, and colorectal.